Michiko Kelley - Chromadex Corp Chief Officer
| CDXCDelisted Stock | USD 7.74 0.13 1.65% |
Executive
Michiko Kelley is Chief Officer of Chromadex Corp
| Phone | 310 388 6706 |
| Web | https://www.chromadex.com |
Chromadex Corp Management Efficiency
The company has return on total asset (ROA) of 0.0784 % which means that it generated a profit of $0.0784 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2294 %, meaning that it created $0.2294 on every $100 dollars invested by stockholders. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Stephen Prior | AN2 Therapeutics | N/A | |
| Jose CPA | Mineralys Therapeutics, Common | 35 | |
| David MD | Nkarta Inc | 47 | |
| Ling Zhou | Adagene | N/A | |
| Greg Mann | Nkarta Inc | N/A | |
| Rebecca Cohen | Ikena Oncology | N/A | |
| Valdas Jurkauskas | Ikena Oncology | N/A | |
| Douglas CPA | Century Therapeutics | N/A | |
| Nicole Esq | HCW Biologics | N/A | |
| Michael Covarrubias | Rezolute | N/A | |
| Stephen Yu | Aerovate Therapeutics | N/A | |
| Gitanjali Jain | Kezar Life Sciences | N/A | |
| Xiaohong She | Adagene | 58 | |
| Sanjeev Khindri | Aerovate Therapeutics | N/A | |
| Alicia Hager | Nkarta Inc | 55 | |
| Danielle Bradbury | Mineralys Therapeutics, Common | N/A | |
| Mark Schiller | Kezar Life Sciences | 45 | |
| Samantha Vuksanic | Ikena Oncology | N/A | |
| Jennifer Huber | AN2 Therapeutics | N/A | |
| Ami Knoefler | Adagene | N/A | |
| David MD | Mineralys Therapeutics, Common | 70 | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0784 |
Chromadex Corp Leadership Team
Elected by the shareholders, the Chromadex Corp's board of directors comprises two types of representatives: Chromadex Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chromadex. The board's role is to monitor Chromadex Corp's management team and ensure that shareholders' interests are well served. Chromadex Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chromadex Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kendall Knysch, Head Partnerships | ||
| Heather Blarcom, Senior Secretary | ||
| Brianna Gerber, Senior Director of FP&A, IR Contact Officer | ||
| Andrew Shao, Senior Affairs | ||
| Frank Jaksch, Co-Founder, CEO and President and Director | ||
| Chu Yan, Managing Pacific | ||
| Ozan CFA, CFO Officer | ||
| Robert Fried, Independent Director | ||
| James Lee, Principal CFO | ||
| David Kroes, Senior Matters | ||
| Jason Campbell, Senior Development | ||
| Michiko Kelley, Chief Officer | ||
| Alex Worsham, Vice Communications | ||
| Tom Shumaker, Managing Advisors | ||
| Fadi Karam, Chief Officer | ||
| Carlos Lopez, Senior Counsel |
Chromadex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chromadex Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0784 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 567.71 M | ||||
| Shares Outstanding | 77.75 M | ||||
| Shares Owned By Insiders | 34.79 % | ||||
| Shares Owned By Institutions | 30.00 % | ||||
| Number Of Shares Shorted | 2.19 M | ||||
| Price To Earning | (19.51) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Chromadex Stock
If you are still planning to invest in Chromadex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chromadex Corp's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |